Synthesis and characterization of D-α-Tocopheryl polyethylene glycol 1000 succinate-block-poly (ε-caprolactone) copolymer used as carriers for microparticles

Journal of Dispersion Science and Technology

Volumn 30, Issue 8, 2009, Pages 1129-1134

  Ren, Fuzheng ^a   Jing, Qiufang ^a   Cui, Jingbin ^a   Shen, Yongjia ^b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Copolymer; D tocopheryl polyethylene glycol 1000 succinate; Microparticle; Poly ( caprolactone)

Indexed keywords

CAPROLACTONE; DRUG DELIVERY SYSTEM; DRUG ENCAPSULATION EFFICIENCY; DRUG-RELEASE RATE; FTIR; IN-VITRO; LASER LIGHT SCATTERING; MICRO-PARTICLES; MICROPARTICLE; RISPERIDONE; SEM; SYNTHESIS AND CHARACTERIZATION; TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATES;

CHROMATOGRAPHIC ANALYSIS; COPOLYMERIZATION; DRUG DELIVERY; EMULSIFICATION; ENCAPSULATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; LIGHT SCATTERING; PLASTIC PRODUCTS; POLYETHYLENE OXIDES; POLYMER BLENDS; SCANNING ELECTRON MICROSCOPY; SYNTHESIS (CHEMICAL); THERMOPLASTICS;

POLYETHYLENE GLYCOLS;

EID: 70449490238     PISSN: 01932691     EISSN: 15322351     Source Type: Journal    
DOI: 10.1080/01932690802701507     Document Type: Article

References (24)

1. Sinha, V.R. and Trehan, A. (2003) J. Controlled Release, 90: 261-280.
2. Jeyanthi, R., Mehta, R.C., Thanoo, B.C., and DeLuca, P.P. (1997) J. Microencapsulation, 14: 163-174.
3. Murillo, M., Gamazo, C., Goni, M., Irache, J., and Blanco-Prieto, M. (2002) Int. J. Pharm., 242: 341-344.
4. Youan, B.B.C., Benoit, M.A., Baras, B., and Gillbard, J. (1999) J. Microencapsulation, 16: 587-599.
5. Perez, M.H., Zinutti, C., Lamprecht, A., Ubrich, N., Astier, A., Hoffman, M., Bodmeier, R., and Maincent, P. (2000) J. Controlled Release, 65: 429-438.
6. Barbato, F., Rotonda, M.I.L., Maglio, G., Palumbo, R., and Quaglia, F. (2001) Biomaterials, 22: 1371-1378.
7. Lu, Z., Bei, J.Z., and Wang, S.G. (1999) J. Controlled Release, 61: 107-112.
8. Shin, S.C., and Kim, J. (2003) International Journal of Pharmaceutics, 251: 79-84.
9. Sokol, R.J., Butler-Simon, N., Conner, C., Hebui, J.E., Sinatra, F.R., Suchy, F.J., Heyman, M.B., Perrault, J., Rothbaum, R.J., Levy, J., Lannaccone, S.T., Shneider, B.L., Koch, T.K., and Narkewicz, M.R. (1993) Gastroenterology, 104: 1727-1735.
10. Mu, L. and Feng, S.S. (2002) J. Controlled Release, 80: 129-44.
11. Chang, T., Benet, L.Z., and Hebert, M.F. (1996) Clin. Pharmacol. Ther., 59: 297-303.
12. Hebert, M.F. (1997) Adv. Drug Deliv. Rev., 27: 201-214.
13. Zhang, Z. and Feng, S.S. (2006) Biomaterials, 27: 262-270.
14. Benoit, M.A., Baras, B., and Gillard, J. (1999) Int. J. Pharm., 184: 73-84.
15. Jiang, W. and Schwendeman, S.P. (2001) Pharm. Res., 18: 878-885.
16. Ubrich, N., Bouillot, P., Pellerin, C., Hoffman, M., and Maincent, P. (2004) J. Controlled Release, 97: 291-300.
17. Holland, S.J., Tighe, B.J., and Gould, P.L. (1986) J. Controlled Release, 4: 155-180.
18. Jansen, P.A.J., Niemegeers, C.J.E., Awouters, F., Schellekens, K.H.L., Megens, A.A.H.P., and Meert, T.F. (1988) J. Pharmacol. Exp. Ther., 244: 685-693.
19. Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G.W., Labelle, A., Beauclair, L., and Arnott, W. A. (1993) J. Clin. Psychopharmacol., 13: 25-40.
20. Eerdekens, M., Hove, I.V., Remmerie B., and Mannaert E. (2004) Schizophrenia Research, 70: 91-100.
21. Zhou, S.B., Deng, X.M., and Yang, H. (2003) Biomaterials, 24: 3563-3570.
22. Storey, R.F. and Sherman, J.W. (2002) Macromolecules, 35: 1504-1512.
23. Schroder, H. and Netscher, T. (2001) Magn. Reson. Chem., 39: 701-708.
24. Leucuta, S.E. (1989) Int. J. Pharm., 54: 71-78.